Skip to main content
. 2017 Mar 6;8(20):32550–32565. doi: 10.18632/oncotarget.15925

Figure 2. Apoptotic effects of ASC+/−ATO in primary leukemic cells.

Figure 2

Primary APL and AML cells were treated with 1 μM ATO, 3 mM ASC or 1 μM ATO + 3 mM ASC and analyzed by FACS after Annexin V-PI staining. PML/RARA positive APL samples (A), AML samples (B), Statistical analysis was performed using the Anova t test and Tukey's Multiple Comparison Test; *p ≤ 0.01; **p ≤ 0.001; ***p ≤ 0.0001; ns: not significant.